These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

8471 related items for PubMed ID: 1533203

  • 1. Immunity to B16 melanoma in mice immunized with IL-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens.
    Kim TS, Russell SJ, Collins MK, Cohen EP.
    Int J Cancer; 1992 May 08; 51(2):283-9. PubMed ID: 1533203
    [Abstract] [Full Text] [Related]

  • 2. Immunization with interleukin-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens prolongs the survival of mice with melanoma.
    Kim TS, Russell SJ, Collins MK, Cohen EP.
    Int J Cancer; 1993 Nov 11; 55(5):865-72. PubMed ID: 8244584
    [Abstract] [Full Text] [Related]

  • 3. Immunization with interleukin-2/interferon-gamma double cytokine-secreting allogeneic fibroblasts prolongs the survival of mice with melanoma.
    Kim TS, Xu WS, Sun T, Cohen EP.
    Melanoma Res; 1995 Aug 11; 5(4):217-27. PubMed ID: 7496156
    [Abstract] [Full Text] [Related]

  • 4. Independent cell types are involved in the induction of antimelanoma responses in C57BL/6 mice immunized with interleukin-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens.
    Kim TS, Collins MK, Cohen EP.
    J Immunother Emphasis Tumor Immunol; 1993 Nov 11; 14(4):298-304. PubMed ID: 7904182
    [Abstract] [Full Text] [Related]

  • 5. Immunity to melanoma in mice immunized with transfected allogeneic mouse fibroblasts expressing melanoma-associated antigens.
    Kim YS, Slomski R, Cohen EP.
    Cancer Immunol Immunother; 1991 Nov 11; 34(3):163-8. PubMed ID: 1756533
    [Abstract] [Full Text] [Related]

  • 6. Immunization of mice with allogeneic fibroblasts genetically modified for interleukin-2-secretion and expression of melanoma-associated antigens stimulate predetermined classes of anti-melanoma effector cells.
    Kim TS, Cohen EP.
    J Immunother Emphasis Tumor Immunol; 1994 Jul 11; 16(1):24-35. PubMed ID: 8081557
    [Abstract] [Full Text] [Related]

  • 7. MHC antigen expression by melanomas recovered from mice treated with allogeneic mouse fibroblasts genetically modified for interleukin-2 secretion and the expression of melanoma-associated antigens.
    Kim TS, Cohen EP.
    Cancer Immunol Immunother; 1994 Mar 11; 38(3):185-93. PubMed ID: 8124687
    [Abstract] [Full Text] [Related]

  • 8. Co-expression of immunogenic determinants by the same cellular immunogen is required for the optimum immunotherapeutic benefit in mice with melanoma.
    Xu W, de Zoeten E, Carr-Brendel V, Cohen EP.
    Cancer Immunol Immunother; 1998 Jan 11; 45(5):217-24. PubMed ID: 9439644
    [Abstract] [Full Text] [Related]

  • 9. Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2.
    Glick RP, Lichtor T, de Zoeten E, Deshmukh P, Cohen EP.
    Neurosurgery; 1999 Oct 11; 45(4):867-74. PubMed ID: 10515482
    [Abstract] [Full Text] [Related]

  • 10. Resistance to melanoma in mice immunized with semiallogeneic fibroblasts transfected with DNA from mouse melanoma cells.
    de Zoeten EF, Carr-Brendel V, Cohen EP.
    J Immunol; 1998 Mar 15; 160(6):2915-22. PubMed ID: 9510195
    [Abstract] [Full Text] [Related]

  • 11. Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma.
    Glick RP, Lichtor T, Mogharbel A, Taylor CA, Cohen EP.
    Neurosurgery; 1997 Oct 15; 41(4):898-906; discussion 906-7. PubMed ID: 9316052
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine melanoma cells prolong the survival of mice with melanoma.
    Kim TS, Cohen EP.
    Cancer Res; 1994 May 15; 54(10):2531-5. PubMed ID: 8168073
    [Abstract] [Full Text] [Related]

  • 13. An optimum anti-melanoma response in mice immunized with fibroblasts transfected with DNA from mouse melanoma cells requires the expression of both syngeneic and allogeneic MHC-determinants.
    de Zoeten EF, Markovic D, Cohen EP.
    Gene Ther; 2002 Sep 15; 9(17):1163-72. PubMed ID: 12170380
    [Abstract] [Full Text] [Related]

  • 14. Immunization with interleukin-2-secreting allogeneic cells transfected with DNA from mouse melanoma cells induces immune responses that prolong the lives of mice with melanoma.
    Sun T, Carr-Brendel V, De Zoeten EF, Cohen EP.
    Cancer Gene Ther; 1998 Sep 15; 5(2):110-8. PubMed ID: 9570302
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine neoplasms induce tumor-specific immune responses that prolong the lives of tumor-bearing mice.
    Sun T, Kim TS, Waltz MR, Cohen EP.
    Cancer Gene Ther; 1995 Sep 15; 2(3):183-90. PubMed ID: 8528961
    [Abstract] [Full Text] [Related]

  • 16. Identification of immunogenic B16 melanoma-associated antigens.
    Johnston D, Schachne JP, Bystryn JC.
    J Biol Response Mod; 1987 Apr 15; 6(2):108-20. PubMed ID: 3585408
    [Abstract] [Full Text] [Related]

  • 17. Fibroblasts genetically engineered to secrete cytokines suppress tumor growth and induce antitumor immunity to a murine glioma in vivo.
    Glick RP, Lichtor T, Kim TS, Ilangovan S, Cohen EP.
    Neurosurgery; 1995 Mar 15; 36(3):548-55. PubMed ID: 7753355
    [Abstract] [Full Text] [Related]

  • 18. Survival and toxicity of an allogeneic cytokine-secreting fibroblast vaccine in the central nervous system.
    Griffitt W, Glick RP, Lichtor T, Cohen EP.
    Neurosurgery; 1998 Feb 15; 42(2):335-40. PubMed ID: 9482184
    [Abstract] [Full Text] [Related]

  • 19. A single heteroclitic epitope determines cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigen.
    Gold JS, Ferrone CR, Guevara-Patiño JA, Hawkins WG, Dyall R, Engelhorn ME, Wolchok JD, Lewis JJ, Houghton AN.
    J Immunol; 2003 May 15; 170(10):5188-94. PubMed ID: 12734366
    [Abstract] [Full Text] [Related]

  • 20. Prolongation of the survival of breast cancer-bearing mice immunized with GM-CSF-secreting syngeneic/allogeneic fibroblasts transfected with a cDNA expression library from breast cancer cells.
    Kim TS, Jung MY, Cho D, Cohen EP.
    Vaccine; 2006 Oct 30; 24(42-43):6564-73. PubMed ID: 16837111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 424.